Monkeypox Virus Seroprevalence among Adults Assessed at Roadside Wellness Centers along Major Transportation Corridor, Kenya, 2025

Authors: Hines, Jonas Z; Lagat, Damaris; Kikwai, Gilbert; Kagecha, Cyrus; Mwazighe, Henry; Ochieng, Caroline; Mwai, Eva; Langat, Daniel; Koech, Emily; Mwachari, Christina; Lucchi, Naomi

Source journal: Emerging infectious diseases (2026-12-01)

DOI: 10.3201/eid3212.260957

Abstract

Since 2024, Kenya has confirmed >1,000 cases of monkeypox virus (MPXV) infection. We conducted a cross-sectional serosurvey at 8 clinics along a transportation corridor in Kenya to quantify unrecognized MPXV transmission. From September 29-October 28, 2025, adults >18 years completed a questionnaire and provided blood samples tested with a serologic assay that distinguishes likely MPXV infection from orthopoxvirus vaccination. We used a modified Poisson regression to assess associations with likely MPXV infection. We compared participants with serologic evidence of MPXV infection to those self-reporting prior confirmed mpox cases. Of 2,896 participants, 332 (11.5%) were seropositive, including 82 (2.8%) classified as likely MPXV infection. Four participants reported prior confirmed MPXV cases, yielding a 21:1 ratio of participants with serologic evidence of MPXV infection to self-reported confirmed cases. Despite some evidence of undetected transmission, most participants lacked serologic evidence of prior orthopoxvirus exposure, indicating a large susceptible population and supporting additional vaccination and ongoing serosurveillance.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.